BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 34529349)

  • 1. Desialylation of O-glycans activates von Willebrand factor by destabilizing its autoinhibitory module.
    Voos KM; Cao W; Arce NA; Legan ER; Wang Y; Shajahan A; Azadi P; Lollar P; Zhang XF; Li R
    J Thromb Haemost; 2022 Jan; 20(1):196-207. PubMed ID: 34529349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A discontinuous autoinhibitory module masks the A1 domain of von Willebrand factor.
    Deng W; Wang Y; Druzak SA; Healey JF; Syed AK; Lollar P; Li R
    J Thromb Haemost; 2017 Sep; 15(9):1867-1877. PubMed ID: 28692141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delimiting the autoinhibitory module of von Willebrand factor.
    Deng W; Voos KM; Colucci JK; Legan ER; Ortlund EA; Lollar P; Li R
    J Thromb Haemost; 2018 Oct; 16(10):2097-2105. PubMed ID: 30053340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet GpIba binding to von Willebrand Factor under fluid shear:contributions of the D′D3-domain, A1-domain flanking peptide and O-linked glycans.
    Madabhushi SR; Zhang C; Kelkar A; Dayananda KM; Neelamegham S
    J Am Heart Assoc; 2014 Oct; 3(5):e001420. PubMed ID: 25341886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoinhibitory module underlies species difference in shear activation of von Willebrand factor.
    Arce NA; Liu Y; Chen W; Zhang XF; Li R
    J Thromb Haemost; 2022 Nov; 20(11):2686-2696. PubMed ID: 36031939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The N-terminal flanking region of the A1 domain regulates the force-dependent binding of von Willebrand factor to platelet glycoprotein Ibα.
    Ju L; Dong JF; Cruz MA; Zhu C
    J Biol Chem; 2013 Nov; 288(45):32289-32301. PubMed ID: 24062306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Purified A2 domain of von Willebrand factor binds to the active conformation of von Willebrand factor and blocks the interaction with platelet glycoprotein Ibalpha.
    Martin C; Morales LD; Cruz MA
    J Thromb Haemost; 2007 Jul; 5(7):1363-70. PubMed ID: 17389010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of von Willebrand factor domain A1 with platelet glycoprotein Ibalpha-(1-289). Slow intrinsic binding kinetics mediate rapid platelet adhesion.
    Miura S; Li CQ; Cao Z; Wang H; Wardell MR; Sadler JE
    J Biol Chem; 2000 Mar; 275(11):7539-46. PubMed ID: 10713059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Desialylation of
    Wang Y; Chen W; Zhang W; Lee-Sundlov MM; Casari C; Berndt MC; Lanza F; Bergmeier W; Hoffmeister KM; Zhang XF; Li R
    Haematologica; 2021 Jan; 106(1):220-229. PubMed ID: 31974202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet glycoprotein Ibalpha forms catch bonds with human WT vWF but not with type 2B von Willebrand disease vWF.
    Yago T; Lou J; Wu T; Yang J; Miner JJ; Coburn L; López JA; Cruz MA; Dong JF; McIntire LV; McEver RP; Zhu C
    J Clin Invest; 2008 Sep; 118(9):3195-207. PubMed ID: 18725999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a novel 14-3-3zeta binding site within the cytoplasmic domain of platelet glycoprotein Ibalpha that plays a key role in regulating the von Willebrand factor binding function of glycoprotein Ib-IX.
    Yuan Y; Zhang W; Yan R; Liao Y; Zhao L; Ruan C; Du X; Dai K
    Circ Res; 2009 Dec; 105(12):1177-85. PubMed ID: 19875727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Type 2B von Willebrand disease mutations differentially perturb autoinhibition of the A1 domain.
    Legan ER; Liu Y; Arce NA; Parker ET; Lollar P; Zhang XF; Li R
    Blood; 2023 Mar; 141(10):1221-1232. PubMed ID: 36580664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure and function of the von Willebrand factor A1 domain: analysis with monoclonal antibodies reveals distinct binding sites involved in recognition of the platelet membrane glycoprotein Ib-IX-V complex and ristocetin-dependent activation.
    De Luca M; Facey DA; Favaloro EJ; Hertzberg MS; Whisstock JC; McNally T; Andrews RK; Berndt MC
    Blood; 2000 Jan; 95(1):164-72. PubMed ID: 10607699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of peptide antagonists to glycoprotein Ibalpha that selectively inhibit von Willebrand factor dependent platelet aggregation.
    Benard SA; Smith TM; Cunningham K; Jacob J; DeSilva T; Lin L; Shaw GD; Kriz R; Kelleher KS
    Biochemistry; 2008 Apr; 47(16):4674-82. PubMed ID: 18363340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A mechanism for localized dynamics-driven affinity regulation of the binding of von Willebrand factor to platelet glycoprotein Ibα.
    Liu G; Fang Y; Wu J
    J Biol Chem; 2013 Sep; 288(37):26658-67. PubMed ID: 23902764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The soluble N-terminal autoinhibitory module of the A1 domain in von Willebrand factor partially suppresses its catch bond with glycoprotein Ibα in a sandwich complex.
    Zhao YC; Li Z; Ju LA
    Phys Chem Chem Phys; 2022 Jun; 24(24):14857-14865. PubMed ID: 35698887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specific electrostatic interactions between charged amino acid residues regulate binding of von Willebrand factor to blood platelets.
    Interlandi G; Yakovenko O; Tu AY; Harris J; Le J; Chen J; López JA; Thomas WE
    J Biol Chem; 2017 Nov; 292(45):18608-18617. PubMed ID: 28924049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conformational activation and inhibition of von Willebrand factor by targeting its autoinhibitory module.
    Arce NA; Markham-Lee Z; Liang Q; Najmudin S; Legan ER; Dean G; Su AJ; Wilson MS; Sidonio RF; Lollar P; Emsley J; Li R
    Blood; 2024 May; 143(19):1992-2004. PubMed ID: 38290109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-Based Cyclic Glycoprotein Ibα-Derived Peptides Interfering with von Willebrand Factor-Binding, Affecting Platelet Aggregation under Shear.
    Hrdinova J; Fernández DI; Ercig B; Tullemans BME; Suylen DPL; Agten SM; Jurk K; Hackeng TM; Vanhoorelbeke K; Voorberg J; Reutelingsperger CPM; Wichapong K; Heemskerk JWM; Nicolaes GAF
    Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glycosylation sterically inhibits platelet adhesion to von Willebrand factor without altering intrinsic conformational dynamics.
    Tischer A; Machha VR; Moon-Tasson L; Benson LM; Auton M
    J Thromb Haemost; 2020 Jan; 18(1):79-90. PubMed ID: 31479573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.